Zobrazeno 1 - 10
of 203
pro vyhledávání: '"painful physical symptoms"'
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 16, Pp 3063-3070 (2020)
Norio Sugawara,1,* Norio Yasui-Furukori,1,* Toshinaga Tsuji,2 Shinji Hayashi,2 Yoshikazu Ajisawa,3 Toshimitsu Ochiai,3 Hideyuki Imagawa,4 Kazutaka Shimoda1 1Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan; 2Medi
Externí odkaz:
https://doaj.org/article/175f19f954c14e6a945dddd02e16e9e0
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 809-817 (2019)
Atsushi Kuga,1,* Tempei Otsubo,2,* Toshinaga Tsuji,3 Shinji Hayashi,3 Hideyuki Imagawa,1 Shinji Fujikoshi,1 Rodrigo Escobar4 1Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan; 2Department of Psychiatry, Tokyo Women’s Medical Univ
Externí odkaz:
https://doaj.org/article/6b44c57f580c4bd19320fce47f0e7f68
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 13, Pp 2437-2445 (2017)
Eiji Harada,1 Yoichi Satoi,2 Atsushi Kuga,1 Hirofumi Tokuoka,1 Toshiaki Kikuchi,3 Koichiro Watanabe,4 Levent Alev,1 Masaru Mimura3 1Biomedicine, Medicines Development Unit Japan, Eli Lilly Japan K.K, Kobe, Japan; 2Statistical Science, Eli Lilly Japan
Externí odkaz:
https://doaj.org/article/41e4031ced4c41c2a055a3b0621641eb
Publikováno v:
Drugs in Context, Pp 1-16 (2013)
Objective: Major depressive disorder (MDD) is a significant public health concern and challenges health care providers to intervene with appropriate treatment. This article provides an overview of efficacy and safety information for duloxetine 60 mg/
Externí odkaz:
https://doaj.org/article/e06d31897a8f42b6ad73f3d6b3c49697
Autor:
Toshinaga Tsuji, Shinji Hayashi, Kazutaka Shimoda, Norio Sugawara, Yoshikazu Ajisawa, Hideyuki Imagawa, Norio Yasui-Furukori, Toshimitsu Ochiai
Publikováno v:
Neuropsychiatric Disease and Treatment
Norio Sugawara,1,* Norio Yasui-Furukori,1,* Toshinaga Tsuji,2 Shinji Hayashi,2 Yoshikazu Ajisawa,3 Toshimitsu Ochiai,3 Hideyuki Imagawa,4 Kazutaka Shimoda1 1Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan; 2Medi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Zdravniški Vestnik, Vol 82, Iss 2 (2013)
Backg round: Depressive symptoms in patients with chronic pain (organic or functional) are well recognized. However, studies on pain were mostly conducted in non-psychiatric settings, and there is a paucity of data on painful physical symptoms (PPS)
Externí odkaz:
https://doaj.org/article/40d39c3f794545ceb316b604b6eeefba
Autor:
Dzmitry Krupchanka, Rahul Shidhaye, Tessa Roberts, Sujit D Rathod, Georgina Miguel Esponda, Vikram Patel
Publikováno v:
BMC Psychiatry, Vol 18, Iss 1, Pp 1-19 (2018)
BMC Psychiatry
BMC Psychiatry
Background There is a large treatment gap for common mental disorders (CMD), with wide variation by world region. This review identifies factors associated with formal health service utilisation for CMD in the general adult population, and compares e
Publikováno v:
Neuropsychiatric Disease and Treatment
Eiji Harada,1 Yoichi Satoi,2 Toshiaki Kikuchi,3 Koichiro Watanabe,3 Levent Alev,1 Masaru Mimura4 1Medical Science, Medicines Development Unit-Japan, 2Statistical Science, Medicines Development Unit-Japan, Eli Lilly Japan K.K., Kobe, Hyogo, 3Departmen